加味苓桂术甘颗粒治疗非酒精性脂肪肝（痰瘀互结证）的临床的研究

《加味苓桂术甘颗粒治疗非酒精性脂肪肝（痰瘀互结证）的临床的研究》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、目录中文摘要···················································1英文摘要···················································3引言····················································5正文····················································71.研究对象···················································71.1病例来源···

2、···············································71.2诊断标准··················································71.3纳入标准··················································81.4排除标准··················································91.5剔除标准··················································92.研究方法······

3、············································92.1分组方法··················································92.2治疗方法··················································92.3观察指标················································102.4疗效判定标准············································112.5统计分析方法··········

4、··································123.研究结果···············································123.1治疗前资料比较·······································123.1.1两组一般项目比较·····································123.1.2两组治疗前肝功能、血脂、证候积分比较···················133.2治疗结果比较·········································133.

5、2.1两组治疗前后ALT、AST、TC、TG比较···················133.2.2两组治疗前后证候积分比较······························143.2.3两组证候疗效比较·····································143.2.4两组治疗前后超声改善情况比较·························143.2.5两组综合疗效比较·····································153.2.6不良反应·······································

6、·····154.讨论·····················································154.1立题依据················································154.2组方思路················································154.3现代医学对NAFLD的认识··································164.4中医学对NAFLD的认识····································174.5小结··

7、·················································19结论··················································20参考文献··················································21附录··················································23综述·······························